Bio Usawa Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-17.
Bio Usawa Inc. filed a Form D notice of an exempt securities offering with the SEC on December 17, 2025. The filing reports $404K sold. Its industry group is Biotechnology. It names Menghis Bairu (Executive Officer, Director), Richard Chin (Director), John Hautman (Executive Officer) (SEC Form D, December 17, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Bio Usawa Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Bio Usawa Inc.
Free to see. No signup.
More on the people and the money behind Bio Usawa Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in December 2025, largest first.
Get an email when Bio Usawa Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Bio Usawa Inc. raises, hires or launches. No email unless you switch it on.
Watch Bio Usawa Inc. →Get the full cited report on Bio Usawa Inc.
What the filing shows about Bio Usawa Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Bio Usawa Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Bio Usawa Inc.'s address as 100 Pine Street, Suite 1250, San Francisco, CA 94111.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Bio Usawa Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Bio Usawa Inc. is a registered filer with the SEC (CIK 2095500) and has filed since 2025-12-17. 3 filings are on record, the latest on 2025-12-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Bio Usawa Inc.'s Form D of 2025-12-17 names Menghis Bairu, Richard Chin, John Hautman and 1 more as its officers, directors or promoters.
Its new offerings report $2.56M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $404K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Menghis Bairu is named as Executive Officer and Director on the Form D that Bio Usawa Inc. filed with the SEC on 17 December 2025, one of 4 people that filing names.
Richard Chin is named as Director on the Form D that Bio Usawa Inc. filed with the SEC on 17 December 2025, one of 4 people that filing names.
John Hautman is named as Executive Officer on the Form D that Bio Usawa Inc. filed with the SEC on 17 December 2025, one of 4 people that filing names.
Vincent Ancinetti is named as Director on the Form D that Bio Usawa Inc. filed with the SEC on 17 December 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-12-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Bio Usawa Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Bio Usawa Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bio Usawa Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Bio Usawa Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Bio Usawa Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Bio Usawa Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/bio-usawa-inc-form-d-25000002